Dow Down 0.45% Nasdaq Up 0.04%

United Therapeutics Corporation (UTHR)

-NMS
114.45 Down 3.38(2.87%) 1:52PM EDT - Nasdaq Real Time Price
Prev Close:117.83
Open:115.74
Bid:114.47 x 200
Ask:114.55 x 100
1y Target Est:113.50
Beta:1.7
Earnings Date:Oct 27 - Oct 31 (Est.)
Day's Range:114.05 - 119.00
52wk Range:70.95 - 119.00
Volume:857,059
Avg Vol (3m):746,600
Market Cap:5.41B
P/E (ttm):24.86
EPS (ttm):4.60
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
UTHRDown 2.87%5.41B
GILDUp 1.40%164.88B
PFEDown 0.44%185.53B

Key Statistics

Forward P/E (1 yr):11.82
P/S (ttm):4.63
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-14) :8.56
Quarterly EPS Est (Sep-14) :1.96
Mean Recommendation*:2.4
PEG Ratio (5 yr expected):2.75

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

United Therapeutics Corporation, a biotechnology company, develops and commercializes products to address the unmet medical needs of patients with chronic and life-threatening conditions worldwide. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback